Herbalife Thailand Sponsors Academic Seminar

Food and Healthcare Press Releases Friday June 2, 2017 15:55
Bangkok--2 Jun--Francom Asia

Herbalife, a global nutrition company, in collaboration with the Department of Home Economics, Faculty of Agriculture, Kasetsart University, recently sponsored an academic seminar on the topic "Advances in Metabolic Syndrome". Over 140 participants comprising professors, lecturers and medical students attended this event.

Dr. Chin-Kun Wang, an expert in metabolism and nutrition, is a distinguished professor of the Chung Shan Medical University in Taiwan and member of the Herbalife Nutrition Advisory Board (NAB). He shared the latest research updates and data on Metabolic Syndrome - risk factors for heart disease, stroke and diabetes - in Southeast Asia. He also explained the role of well-balanced nutrition in combating obesity, and addressed health issues associated with the lack of physical activity, unbalanced diets, stressful conditions and other concerns linked with today's demanding lifestyle.

During the seminar, Associate Professor Dr. Sirichai Adisakwattana from Chulalongkorn University's Faculty of Allied Health Sciences, also discussed the prevalence of Metabolic Syndrome in Thai children and adults, and its correlation with obesity and overweight. He shared updates on the government's health policies and strategies such as establishing the Food Innopolis at Thailand Science Park, which is an institution that focuses on research, development and innovation for the food industry.

The most recent data from Thailand's Ministry of Public Health (MOPH) revealed that around 17.4 million Thais (26% of the population) were considered overweight, and that there are twice as many obese women than men. The country is among the top five in Asia-Pacific with the highest numbers of cases of obesity. Moreover, the prevalence of Metabolic Syndrome among Thais aged 15 years and over was 32.1% (16.1 million) overall; 18.6% for men and 45% for women.

Latest Press Release

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their...

FDI Global Survey Shows Children are not Getting Dental Check-ups Early Enough

On the occasion of World Oral Health Day, FDI World Dental Federation asked parents around the world how they cared for their children's oral health growing up and the responses suggest room for improvement. Maintaining a healthy mouth is crucial to...

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia...

Johnson Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan,...

Biotherm Hosts the First Biotherm Healing Summit

Biotherm hosted the first "Biotherm Healing Summit" on March 7. A symposium on the theme of skin & healing, focusing on major research that has evidenced the link between micro-organisms and skin health. Unveiling Life PlanktonTM, the healing...

Related Topics